載入...
Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo
Treatment with PPARγ agonists in vivo improves human adipocyte metabolism, but the cellular mechanisms and possible depot differences in responsiveness to their effects are poorly understood. To examine the ex vivo metabolic effects of rosiglitazone (Rosi), we cultured explants of human visceral (om...
Na minha lista:
| 發表在: | J Lipid Res |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The American Society for Biochemistry and Molecular Biology
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446708/ https://ncbi.nlm.nih.gov/pubmed/30782959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M091173 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|